For all studies, the estimated probability of patients using additional treatments for their migraines over the 24 hours following the single 2 mg dose of study treatment is summarized in Figure 3 below
Use the protocol-specified site, angle, and device
Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1980s
We will use our professional testing equipment to test each batch of products to ensure that our products meet the requirements
Munster PN, Troso-Sandoval T, Rosen N, Rifkind R, Marks PA, Richon VM
TRIUMPH-2: obesity with type 2 diabetes